METTL3 and hepatocellular carcinoma: These include (i) METTL3, which increases the glycolytic capacity of HCC cells [98]; (ii) WTAP, which promotes hepatic cancer cells proliferation and tumor growth in vivo [99]; and (iii) the demethylase FTO, which fosters HCC development [100].